Why are analysts favoring Alphabet over Meta?
Analysts cite more conservative Street estimates and a lower valuation for Alphabet shares.
Finance / Stocks
Shares of Alphabet (Google) have outperformed the S&P 500 and Magnificent 7 this year. Analysts are favoring Alphabet over Meta, citing valuation and conservative estimates. Goldman Sachs has raised its price target for Alphabet, reinforcin...
Alphabet Inc. (GOOGL) is recognized for its significant platforms, including Google Search, Google Maps, Gmail, and YouTube. The company is also heavily involved in cloud computing, quantum computing, and artificial intelligence research.
Goldman Sachs highlighted Alphabet as one of the most leveraged artificial intelligence companies, a view increasingly shared by investors. This perspective, combined with the growth of Gemini and core Search, and a more favorable outcome in the Search antitrust verdict, has contributed to the positive re-evaluation of Alphabet’s stock.
Analysts cite more conservative Street estimates and a lower valuation for Alphabet shares.
Goldman Sachs raised its price target for Alphabet to $288 while maintaining a Buy rating.
Growth in usage of Gemini and core Search, along with a favorable Search antitrust verdict.
Do you think Alphabet will continue to outperform Meta? Share your thoughts in the comments!
Share this article with others who need to stay ahead of this trend!
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.